Charles Schwab Investment Management Inc. Lowers Stake in Genpact Limited (NYSE:G)

Charles Schwab Investment Management Inc. cut its stake in Genpact Limited (NYSE:G) by 0.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,117,639 shares of the business services provider’s stock after selling 244 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.63% of Genpact worth $43,823,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in G. Dimensional Fund Advisors LP lifted its position in Genpact by 34.2% during the second quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock valued at $107,065,000 after acquiring an additional 847,249 shares during the last quarter. Vulcan Value Partners LLC increased its position in shares of Genpact by 22.2% during the second quarter. Vulcan Value Partners LLC now owns 1,567,428 shares of the business services provider’s stock worth $50,456,000 after purchasing an additional 284,842 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Genpact by 8.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,512,259 shares of the business services provider’s stock valued at $48,680,000 after purchasing an additional 122,993 shares during the last quarter. Greenhaven Associates Inc. boosted its position in shares of Genpact by 14.1% in the 2nd quarter. Greenhaven Associates Inc. now owns 1,240,775 shares of the business services provider’s stock worth $39,941,000 after purchasing an additional 153,140 shares in the last quarter. Finally, Pzena Investment Management LLC grew its stake in Genpact by 130.3% during the 2nd quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider’s stock worth $37,465,000 after buying an additional 658,560 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Genpact Stock Down 0.7 %

G opened at $46.16 on Monday. The company has a fifty day moving average of $41.17 and a two-hundred day moving average of $37.02. The stock has a market capitalization of $8.14 billion, a price-to-earnings ratio of 12.68, a PEG ratio of 1.59 and a beta of 1.13. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $47.98. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.

Genpact Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be given a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.32%. Genpact’s dividend payout ratio (DPR) is 16.76%.

Wall Street Analyst Weigh In

A number of analysts recently commented on G shares. TD Cowen lifted their target price on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research note on Friday, November 8th. Jefferies Financial Group lifted their price objective on shares of Genpact from $35.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 9th. Needham & Company LLC upped their target price on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. JPMorgan Chase & Co. raised their target price on Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Finally, BMO Capital Markets boosted their price target on Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research note on Monday, August 12th. Eight investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $42.33.

Insider Activity

In related news, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 2.80% of the company’s stock.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.